Breast cancer is the most common cancer in women worldwide. Yet, in many parts of Latin America and Africa, patients wait weeks—sometimes months—for a diagnosis. Every 2-week delay lowers survival chances by 7%. Not because doctors don’t care, but because there simply aren’t enough pathologists.

In underserved regions, a single specialist may need to review hundreds of slides a week. It’s humanly impossible to keep up without help. Lives are lost—not from lack of medicine, but from lack of speed.

That’s why we built Digpatho.

Digpatho is an app that uses artificial intelligence to help pathologists analyze cancer biopsies 5 to 10 times faster, with up to 95% accuracy. It doesn’t replace specialists—it empowers them, giving them tools to detect, correct, and confirm results more efficiently.

With this system, patients can get a diagnosis in hours, not weeks. And in many cases, that time can mean the difference between life and death.

We’ve put in the work:
🧠 4,000+ hours of R&D
👨‍⚕️ A team of 5 pathologists, 7 bioengineers, and 10 developers
🎓 5 PhDs across pathology, AI, industrial engineering, and bioinformatics

We’ve built the system. We’ve validated the tech. We’ve secured interest from hospitals. But to scale up—to integrate with hospital systems, hire key staff, and launch the AI platform—we need you.